Silencing CISD2 reduced the cell proliferation of resistant hepatocellular carcinoma (HCC) cells by increasing ferroptosis, while inhibiting both CISD2 and BECN1 decreased ferroptosis in HCC cells (Li et al., 2021). The gene discussed is BECN1; the disease is hepatocellular carcinoma.